Benjamin Jackson CFA
Stock Analyst at Jefferies
(4.29)
# 1,423
Out of 5,119 analysts
79
Total ratings
67.3%
Success rate
16.4%
Average return
Main Sectors:
Stocks Rated by Benjamin Jackson CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: IPN Ipsen S.A. | Reiterated: Sell | €135.00 → €130.00 | €158.70 | -18.08% | 4 | Oct 8, 2026 | |
| SWX: GALD Galderma Group AG | Reiterated: Buy | CHF 205.00 | CHF 191.75 | +6.91% | 35 | Sep 29, 2026 | |
| GMAB Genmab | Reiterated: Buy | n/a | $53.63 | - | 2 | Aug 7, 2026 | |
| SWX: CMHC Cosmo N.V. | Reiterated: Buy | CHF 140.00 → CHF 110.00 | CHF 56.80 | +93.66% | 3 | Jul 28, 2026 | |
| SWX: NOVN Novartis AG | Reiterated: Hold | CHF 110.00 | CHF 133.08 | -17.34% | 5 | Feb 4, 2026 | |
| EPA: SAN Sanofi | Reiterated: Buy | €100.00 | €83.74 | +19.42% | 9 | Dec 29, 2025 | |
| SWX: ROP Roche Holding AG | Downgraded: Sell | CHF 270.00 → CHF 230.00 | CHF 390.30 | n/a | 6 | Oct 27, 2025 | |
| LON: GSK GSK plc | Reiterated: Hold | 1,450p | 1,890p | n/a | 2 | Jul 30, 2025 | |
| LON: AZN AstraZeneca PLC | Reiterated: Hold | 10,900p | 13,930p | n/a | 2 | Jul 29, 2025 | |
| ETR: EVT Evotec SE | Reiterated: Hold | €6.80 | €3.16 | n/a | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.8 | $1.69 | n/a | 1 | Oct 7, 2024 |
Ipsen S.A.
Oct 8, 2026
Reiterated: Sell
Price Target: €135.00 → €130.00
Current: €158.70
Upside: -18.08%
Galderma Group AG
Sep 29, 2026
Reiterated: Buy
Price Target: CHF 205.00
Current: CHF 191.75
Upside: +6.91%
Genmab
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $53.63
Upside: -
Cosmo N.V.
Jul 28, 2026
Reiterated: Buy
Price Target: CHF 140.00 → CHF 110.00
Current: CHF 56.80
Upside: +93.66%
Novartis AG
Feb 4, 2026
Reiterated: Hold
Price Target: CHF 110.00
Current: CHF 133.08
Upside: -17.34%
Sanofi
Dec 29, 2025
Reiterated: Buy
Price Target: €100.00
Current: €83.74
Upside: +19.42%
Roche Holding AG
Oct 27, 2025
Downgraded: Sell
Price Target: CHF 270.00 → CHF 230.00
Current: CHF 390.30
Upside: n/a
GSK plc
Jul 30, 2025
Reiterated: Hold
Price Target: 1,450p
Current: 1,890p
Upside: n/a
AstraZeneca PLC
Jul 29, 2025
Reiterated: Hold
Price Target: 10,900p
Current: 13,930p
Upside: n/a
Evotec SE
Nov 13, 2024
Reiterated: Hold
Price Target: €6.80
Current: €3.16
Upside: n/a
Oct 7, 2024
Downgraded: Hold
Price Target: $3.8
Current: $1.69
Upside: n/a